FDA has relaxed its advice on when, where and how often companies need to include the generic name of a product in advertising and promotional labeling in a Nov. 18 draft guidance.
For instance, the draft says FDA intends to exercise enforcement discretion if the generic name of a drug,...
Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?